Skip to content

Screener

Eligibility screening

CBX-12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

Sponsored by Cybrexa TherapeuticsStudy detailsClinicalTrials.gov

17 US sites in AZ, CA, CT, FL +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.